207 related articles for article (PubMed ID: 23640861)
1. Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice.
Seth RK; Kumar A; Das S; Kadiiska MB; Michelotti G; Diehl AM; Chatterjee S
Toxicol Sci; 2013 Aug; 134(2):291-303. PubMed ID: 23640861
[TBL] [Abstract][Full Text] [Related]
2. CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.
Seth RK; Das S; Kumar A; Chanda A; Kadiiska MB; Michelotti G; Manautou J; Diehl AM; Chatterjee S
Toxicol Appl Pharmacol; 2014 Jan; 274(1):42-54. PubMed ID: 24211274
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory adipokine leptin mediates disinfection byproduct bromodichloromethane-induced early steatohepatitic injury in obesity.
Das S; Kumar A; Seth RK; Tokar EJ; Kadiiska MB; Waalkes MP; Mason RP; Chatterjee S
Toxicol Appl Pharmacol; 2013 Jun; 269(3):297-306. PubMed ID: 23438451
[TBL] [Abstract][Full Text] [Related]
4. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
Alhasson F; Dattaroy D; Das S; Chandrashekaran V; Seth RK; Schnellmann RG; Chatterjee S
Am J Physiol Renal Physiol; 2016 Jan; 310(1):F85-F101. PubMed ID: 26447219
[TBL] [Abstract][Full Text] [Related]
5. Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.
Chandrashekaran V; Das S; Seth RK; Dattaroy D; Alhasson F; Michelotti G; Nagarkatti M; Nagarkatti P; Diehl AM; Chatterjee S
Biochim Biophys Acta; 2016 Jan; 1862(1):32-45. PubMed ID: 26474534
[TBL] [Abstract][Full Text] [Related]
6. Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis.
Das S; Seth RK; Kumar A; Kadiiska MB; Michelotti G; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G950-63. PubMed ID: 24157968
[TBL] [Abstract][Full Text] [Related]
7. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.
Abdelmegeed MA; Banerjee A; Jang S; Yoo SH; Yun JW; Gonzalez FJ; Keshavarzian A; Song BJ
Free Radic Biol Med; 2013 Dec; 65():1238-1245. PubMed ID: 24064383
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
9. Etiopathogenesis of nonalcoholic steatohepatitis.
Chitturi S; Farrell GC
Semin Liver Dis; 2001; 21(1):27-41. PubMed ID: 11296694
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin.
Ge JF; Walewski JL; Anglade D; Berk PD
Semin Liver Dis; 2016 Sep; 36(4):360-372. PubMed ID: 27997977
[TBL] [Abstract][Full Text] [Related]
11. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis.
Abdelmegeed MA; Banerjee A; Yoo SH; Jang S; Gonzalez FJ; Song BJ
J Hepatol; 2012 Oct; 57(4):860-6. PubMed ID: 22668639
[TBL] [Abstract][Full Text] [Related]
12. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.
Gopal T; Kumar N; Perriotte-Olson C; Casey CA; Donohue TM; Harris EN; Talmon G; Kabanov AV; Saraswathi V
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G428-G438. PubMed ID: 31928222
[TBL] [Abstract][Full Text] [Related]
13. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
16. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
Leclercq IA; Farrell GC; Field J; Bell DR; Gonzalez FJ; Robertson GR
J Clin Invest; 2000 Apr; 105(8):1067-75. PubMed ID: 10772651
[TBL] [Abstract][Full Text] [Related]
17. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
J Obes; 2013; 2013():296537. PubMed ID: 23401753
[TBL] [Abstract][Full Text] [Related]
18. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
Ezquer M; Ezquer F; Ricca M; Allers C; Conget P
J Hepatol; 2011 Nov; 55(5):1112-20. PubMed ID: 21356258
[TBL] [Abstract][Full Text] [Related]
19. M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.
Seth RK; Das S; Pourhoseini S; Dattaroy D; Igwe S; Ray JB; Fan D; Michelotti GA; Diehl AM; Chatterjee S
J Pharmacol Exp Ther; 2015 Jan; 352(1):77-89. PubMed ID: 25347994
[TBL] [Abstract][Full Text] [Related]
20. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.
Sahai A; Malladi P; Pan X; Paul R; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1035-43. PubMed ID: 15256362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
